Late-term smoking cessation despite initial failure: An evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo

Clinical Therapeutics

Volumn 23, Issue 5, 2001, Pages 744-752

  Jamerson, Brenda D ^a   Nides, Mitchell ^b   Jorenby, Douglas E ^c   Donahue, Rafe ^a   Garrett, Peter ^a   Johnston, J Andrew ^a   Fiore, Michael C ^c   Rennard, Stephen I ^d   Leischow, Scott J ^e  

^a GLAXOSMITHKLINE   (United States)

^b Los Angeles Clinical Trials   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e Arizona Prog for Nicotine/T   (United States)

Author keywords

Bupropion SR; Nicotine patch; Smoking; Smoking cessation

Indexed keywords

AMFEBUTAMONE; NICOTINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; SUSTAINED RELEASE FORMULATION; TREATMENT FAILURE; XEROSTOMIA;

EID: 0035011737     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80023-0     Document Type: Article

References (13)

1. 1. Smoking cessation during previous year among adults - United States, 1990 and 1991. MMWR Morb Mortal Wkly Rep. 1993;42:504-507.
2. 2. Hunt WA, Bespalec DA. An evaluation of current methods of modifying smoking behavior. J Clin Psychol. 1974;30:431-438.
3. 3. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence. A US Public Health Service report. JAMA. 2000;283:3244-3254.
4. 4. Hurt RD, Sachs DPL, Glover ED. et al. A comparison of sustained release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337:1195-1202.
5. 5. Kenford SL, Fiore MC, Jorenby DE, et al. Predicting smoking cessation: Who will quit with and without the nicotine patch? JAMA. 1994;271:589-594.
6. 6. Westman EC, Behm FM, Simel DL, Rose JE, Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Arch Intern Med. 1997;157:335-340.
7. 7. Chornock WM, Stitzer ML, Gross J, Leischow S. Experimental model of smoking re-exposure: Effects on relapse. Psychopharmacology. 1992;108:455-500.
8. 8. Jorenby DE, Leischow SJ. Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999; 340:685-691.
9. 9. Daughton DM. Fortmann SP. Glover ED. et al. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med. 1999;2:113-118.
10. 10. Hughes JR, Goldslein MG, Hurt RD, Shiftman S. Recent advances in the pharmacotherapy of smoking. JAMA. 1999; 281:72-76,
11. 11. Jorenby DE, Smith SS, Fiore MC, et al. Varying nicotine patch dose and type of smoking cessation counseling. JAMA. 1995;274:1347-1352.
12. 12. Richmond RL, Harris K, de Almeida Neto A. The transdermal nicotine patch: Results of a randomised placebo-controlled trial. Med J Aust. 1994;161:130-135.
13. 13. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med. 1995;155:1933-1941.